Biosite Announces Presentation at Nasdaq's 17th Annual Investor Program

SAN DIEGO, June 16  /PRNewswire-FirstCall/ -- Biosite Incorporated (NASDAQ:BSTE) today announced that Gunars Valkirs, Ph.D, senior vice president, Biosite Discovery, will discuss the Company's operating environment, products and research and development activities at Nasdaq's 17th Annual Investor Program.  The conference will be held at the Renaissance Chancery Court in London.  Biosite's presentation will take place June 21, 2006, at 4:30 p.m. Greenwich Mean Time.

A link to the live audio webcast can be accessed through the Biosite website, http://www.biosite.com/.  The Biosite presentation will be archived on the website until July 12, 2006 in the Investor Center under Events Calendar.

About Biosite Incorporated

Biosite Incorporated is a leading bio-medical company commercializing proteomics discoveries for the advancement of medical diagnosis.  The Company's products contribute to improvements in medical care by aiding physicians in the diagnosis of critical diseases and health conditions. Biosite's Triage(R) rapid diagnostics are used in approximately 50 percent of U.S. hospitals and in more than 60 international markets.  Information on Biosite can be found at http://www.biosite.com/.

Biosite(R), Triage(R) and New Dimensions in Diagnosis(R) are registered trademarks of Biosite Incorporated. The Company's logo is a trademark of Biosite Incorporated. 

DATASOURCE: Biosite Incorporated



CONTACT:  Nadine Padilla, Vice President, Corporate and Investor

Relations of Biosite Incorporated, [phone], 



Web site:  http://www.biosite.com/ 



Company News On-Call:  http://www.prnewswire.com/comp/116737.html 

Copyright